Sino Biopharmaceutical stock

1177 · HKEX · HKD

Compare Sino Biopharmaceutical
$5.11Change from previous close: −4.85%Absolute change: −$0.26

Close · November 20, 2026

Price history

−27.38% over the period

1 year: from $7.03 (November 20, 2025) to $5.11 (November 20, 2026), −27.38%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$5.11
October 30, 2026$4.82
September 30, 2026$5.71
August 31, 2026$5.45
July 31, 2026$5.03
June 30, 2026$4.41
May 29, 2026$4.99
April 30, 2026$5.42
March 31, 2026$5.89
February 27, 2026$6.05
January 30, 2026$6.64
December 31, 2025$6.18
November 28, 2025$7.05
November 20, 2025$7.03

At a glance

  • The company

    Chinese biopharmaceutical company developing and commercializing oncology, liver disease, respiratory and surgery/analgesia medicines

  • Latest results

    Quarter to June 30, 2026 · EPS ¥0.19

TickerLandia's take on Sino Biopharmaceutical

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$4.19
52-wk high$7.30

−30.07% from the 52-week high

Analysts · 23 analysts

Average target$8.49+66.23% vs. price

Buy 21 · Hold 2 · Sell 0 · Strong buy

TickerLandia Fingerprint: Sino Biopharmaceutical

Compared with similar companies: very high earnings stability and very high dividend.

Financials and price compared with 61 companies in the biotechnology industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Sino Biopharmaceutical is cheaper than similar companies

Sino Biopharmaceutical's P/E (trailing 12 months): 34.2, −7% against the median of a group of 8 similar companies (36.8).

Compared with 8 similar companies

Sino Biopharmaceutical's metrics compared with similar companies
MetricSino BiopharmaceuticalPosition in the groupBand
P/E (trailing 12 months)34.2Middle
Forward P/E15.8Low
Operating margin28.2%Middle
ROE14.1%Middle
Debt/equity0.37Middle

Grey band: the middle half of the group; tick: the median; dot: Sino Biopharmaceutical. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

¥19.44B

Latest quarter · Q2 2026

Net income

¥3.43B

Latest quarter · Q2 2026

Quarterly net margin

17.7%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$91.32B
P/E
34.2
EPS
$0.15
Volume
10.85M
Daily trading
€46.07M
Dividend yield
2.35%
Last ex-dividend on September 1, 2026

How Sino Biopharmaceutical is changing

All results
  • Revenue grew 6.1% a year on average over the last 5 years

  • Shares outstanding down 4.0% in 5 years

  • Revenue has grown for 3 fiscal years in a row

Returns

Sino Biopharmaceutical returns with dividends

$1,000 invested in Sino Biopharmaceutical 5 years ago, on November 22, 2021, would be worth $990 today with dividends reinvested: −1.02% in total, −0.20% per year. On price alone it would be $889 (−11.06%).

PeriodSino BiopharmaceuticalHang Seng$1,000 becomes
1 month−5.46%−6.10%$945
6 months−1.26%−12.63%$987
Year to date−17.39%−12.56%$826
1 year−25.58%−13.26%$744
3 years+41.73%+26.06%$1,417
5 years−1.02%−10.18%$990
10 years+143.11%+0.24%$2,431

Over the last 6 months it has done better than 42% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Hang Seng: price only. Calculate your investment

The chart in detail

Sino Biopharmaceutical: technical analysis

Sino Biopharmaceutical is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 53.1% below its all-time closing high ($10.88, July 23, 2020).

Trend
Downward
RSI (14 sessions)
41
Between 30 and 70
vs 200-session average
−6.42%

Support and resistance

Price areas where Sino Biopharmaceutical has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$5.72+11.98%3 touches, last on November 9, 2026
  2. Resistance$5.51+7.86%4 touches, last on October 21, 2026
  3. Resistance$5.26+3.04%4 touches, last on September 14, 2026
  4. Last price$5.11
  5. Support$4.88−4.51%2 touches, last on July 17, 2026
  6. Support$4.74−7.23%5 touches, last on November 2, 2026
  7. Support$4.19−17.92%2 touches, last on June 29, 2026

Volatility and risk

Over the last year it has moved roughly in line with the Hang Seng.

Beta (1 year) vs Hang Seng
1.13
Volatility (60 sessions, annualised)
47.6%
Largest fall in the last year
−40.08%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Sino Biopharmaceutical: seasonality

Average monthly price change over 27 years

−0.5%Jan+8.0%Feb+3.8%Mar+4.2%Apr+2.9%May+1.0%Jun+5.4%Jul−0.4%Aug−0.8%Sep−0.4%Oct+5.6%Nov−0.4%Dec

Over the last 27 years, the strongest month for Sino Biopharmaceutical has been February: +8.05% on average, positive in 17 years out of 26. The weakest has been September: −0.80% on average, positive in 10 years out of 26. November, the current month, has been positive in 11 years out of 26 (+5.62% on average).

Show chart data
MonthAverageMedianPositive years
January−0.55%−0.22%10 of 26
February+8.05%+8.33%17 of 26
March+3.79%+1.00%13 of 26
April+4.22%+0.48%13 of 26
May+2.88%+4.15%16 of 26
June+1.02%−0.68%8 of 26
July+5.40%+2.90%15 of 26
August−0.37%−0.90%11 of 26
September−0.80%0.00%10 of 26
October−0.43%0.00%13 of 27
November+5.62%0.00%11 of 26
December−0.41%−0.86%8 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Sino Biopharmaceutical and its competitors

Based in Wan Chai, Hong Kong, and incorporated in 2000, Sino Biopharmaceutical Limited is an investment holding company whose operations centre on the research, development and sale of pharmaceuticals in the People's Republic of China. The group reports through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others.

Headquarters
Wan Chai, Hong Kong
Employees
22,838
Founded
2000
Chief executive
S. Y. Tse
Sino Biopharmaceutical and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Sino Biopharmaceutical1177$11.65B28.2%34.2−1.26%
Pharmaron Beijing300759$10.59B14.0%39.3+44.36%
Sichuan Kelun-Biotech Biopharmaceutical6990$12.15B-0.2%—−8.83%
ALTEOGEN196170$9.05B47.2%97.1−36.93%
Haisco Pharmaceutical Group002653$8.97B21.1%44.1+0.54%
Genscript Biotech1548$8.77B14.9%—+112.07%

Same industry or related industries, similar size. Compare Sino Biopharmaceutical with its competitors · Full profile